287 related articles for article (PubMed ID: 16084712)
21. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
[TBL] [Abstract][Full Text] [Related]
22. Fetal-cell microchimerism, lymphopoiesis, and autoimmunity.
Leduc M; Aractingi S; Khosrotehrani K
Arch Immunol Ther Exp (Warsz); 2009; 57(5):325-9. PubMed ID: 19707719
[TBL] [Abstract][Full Text] [Related]
23. Possible roles and determinants of microchimerism in autoimmune and other disorders.
Sarkar K; Miller FW
Autoimmun Rev; 2004 Aug; 3(6):454-63. PubMed ID: 15351311
[TBL] [Abstract][Full Text] [Related]
24. Microchimerism: tolerance vs. sensitization.
Dutta P; Burlingham WJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):359-65. PubMed ID: 21666480
[TBL] [Abstract][Full Text] [Related]
25. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
Bhattacharyya S; Cowan MJ
Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
[TBL] [Abstract][Full Text] [Related]
26. The influence of inherited and noninherited parental antigens on outcome after transplantation.
van den Boogaardt DE; van Rood JJ; Roelen DL; Claas FH
Transpl Int; 2006 May; 19(5):360-71. PubMed ID: 16623871
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive determination of the paternal HLA haplotype of a fetus using kinetic PCR to detect fetal microchimerism in maternal plasma.
Reed W; Kong DZ; Lee TH; Cowan MJ; Busch MP; Baxter-Lowe LA
Bone Marrow Transplant; 2002 Mar; 29(6):527-9. PubMed ID: 11960275
[TBL] [Abstract][Full Text] [Related]
28. Non-inherited maternal antigens, pregnancy, and allotolerance.
Bracamonte-Baran W; Burlingham W
Biomed J; 2015; 38(1):39-51. PubMed ID: 25355389
[TBL] [Abstract][Full Text] [Related]
29. Long-term feto-maternal microchimerism revisited: Microchimerism and tolerance in hematopoietic stem cell transplantation.
Ichinohe T
Chimerism; 2010; 1(1):39-43. PubMed ID: 21327150
[TBL] [Abstract][Full Text] [Related]
30. Successful non-T-cell-depleted HLA-haploidentical stem cell transplantation (SCT) with reduced-intensity conditioning from a second child for late graft failure after the first HLA-haploidentical SCT for MDS/overt leukemia based on feto-maternal microchimerism.
Fuchida S; Nakano S; Yamada N; Uchida R; Okano A; Okamoto M; Maruya E; Saji H; Shimazaki C
Bone Marrow Transplant; 2005 May; 35(10):1031-2. PubMed ID: 15806124
[No Abstract] [Full Text] [Related]
31. Fetal microchimerism: the cellular and immunological legacy of pregnancy.
Lissauer DM; Piper KP; Moss PA; Kilby MD
Expert Rev Mol Med; 2009 Nov; 11():e33. PubMed ID: 19909558
[TBL] [Abstract][Full Text] [Related]
32. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
33. [The possible role of microchimerism in the aetiology of autoimmune diseases].
Jansen AG; Vossen JM; Roelen DL; ten Cate R; Bredius RG
Ned Tijdschr Geneeskd; 2005 Jul; 149(28):1556-60. PubMed ID: 16038158
[TBL] [Abstract][Full Text] [Related]
34. Early hematopoietic microchimerism predicts clinical outcome after kidney transplantation.
Pujal JM; Grinyó JM; Gil-Vernet S; Caldes A; Hernández P; Mestre M; Encuentra M; Perez-Garcia A; Gallardo D
Transplantation; 2007 Nov; 84(9):1103-11. PubMed ID: 17998864
[TBL] [Abstract][Full Text] [Related]
35. The tripartite immune conflict in placentals and a hypothesis on fetal-->maternal microchimerism.
Apari P; Rózsa L
Med Hypotheses; 2009 Jan; 72(1):52-4. PubMed ID: 18930355
[TBL] [Abstract][Full Text] [Related]
36. Fetal-maternal exchange of multipotent stem/progenitor cells: microchimerism in diagnosis and disease.
Klonisch T; Drouin R
Trends Mol Med; 2009 Nov; 15(11):510-8. PubMed ID: 19828378
[TBL] [Abstract][Full Text] [Related]
37. Impact of fetal-maternal microchimerism on women's health--a review.
Lapaire O; Hösli I; Zanetti-Daellenbach R; Huang D; Jaeggi C; Gatfield-Mergenthaler S; Hahn S; Holzgreve W
J Matern Fetal Neonatal Med; 2007 Jan; 20(1):1-5. PubMed ID: 17437192
[TBL] [Abstract][Full Text] [Related]
38. In pursuit of the ultimate: the initial Ahmedabad journey toward transplantation tolerance.
Trivedi HL; Vanikar AV; Modi PR; Shah PR; Shah VR; Trivedi VB
Transplant Proc; 2007 Apr; 39(3):653-7. PubMed ID: 17445566
[TBL] [Abstract][Full Text] [Related]
39. No in vitro evidence for a decreased alloreactivity toward noninherited maternal HLA antigens in healthy individuals.
van den Boogaardt DE; van Miert PP; Koekkoek KM; de Vaal YJ; van Rood JJ; Claas FH; Roelen DL
Hum Immunol; 2005 Dec; 66(12):1203-12. PubMed ID: 16690407
[TBL] [Abstract][Full Text] [Related]
40. Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+ CD25+ T-cell-dependent mechanism.
Matsuoka K; Ichinohe T; Hashimoto D; Asakura S; Tanimoto M; Teshima T
Blood; 2006 Jan; 107(1):404-9. PubMed ID: 16150938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
